Skip to main content

Advertisement

Table 1 Baseline characteristics of the total population and stratified into groups according to angiographically verified CAD or not

From: Pro-coagulant activity during exercise testing in patients with coronary artery disease

  Overall (n = 106) (%) CAD (n = 70) No CAD (n = 36) P-value
Age (years) 62 ± 10 63 ± 10 60 ± 10 0.132
Sex (male) 62 (58.5) 47 (67.1) 15 (41.7) 0.012
Smoking (current/past)(%) 61 (57.5) 40 (57.1) 21 (58.3) 0.907
Diabetes (%) 19 (17.9) 15 (21.4) 5 (11.1) 0.190
Hypertension (%) 67 (63.2) 44 (62.9) 23 (63.9) 0.917
Hyperlipidemia (%) 84 (79.2) 59 (84.3) 25 (69.4) 0.074
BMI (kg/m2) 27.8 ± 4 27.9 ± 3.9 27.6 ± 3.8 0.726
Previous CAD (%)     
1.Previous angina 31 (29.2) 27 (38.6) 4 (11.1) 0.003
2.Previous MI 14 (13.2) 12 (17.1) 2 (5.6) 0.132
3.Previous interv. 27 (25.5) 25 (35.7) 2 (5.6) 0.001
Resting SBP (mmHg) 133 ± 22 133 ± 22 133 ± 21 0.928
Resting DBP (mmHg) 84 ± 10 84 ± 11 85 ± 9 0.621
Resting heart rate (bpm) 70 ± 13 68 ± 12 73 ± 13 0.050
ACE-inhib./ARB 43 (40.6) 30 (42.9) 13 (36.1) 0.503
Betablocker 45 (42.5) 35 (50) 10 (27.8) 0.028
Nitrate 9 (8.5) 9 (12.9) 0 0.025
Statin 68 (64.2) 50 (71.4) 18 (50) 0.029
Aspirin 71 (67) 55 (78.6) 16 (44.4) <0.001